Key Points
- Director Thomas Kosasa purchased 1,449,275 OneMedNet shares at an average price of $0.69, investing nearly $1 million and increasing his stake by 8.48% to 18.54 million shares.
- OneMedNet shares opened at $0.62, with a market capitalization of approximately $35.6 million, a 52-week range of $0.44 to $4.22, and recent quarterly revenue of just $0.10 million alongside an EPS loss of $0.04.
- Analyst sentiment remains negative: OneMedNet has an average “Sell” rating, while hedge funds and institutional investors own only about 0.95% of the company.
OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) Director Thomas Kosasa bought 1,449,275 shares of the stock in a transaction dated Thursday, July 30th. The shares were acquired at an average price of $0.69 per share, for a total transaction of $999,999.75. Following the completion of the transaction, the director owned 18,538,150 shares of the company's stock, valued at approximately $12,791,323.50. The trade was a 8.48% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Thomas Kosasa also recently made the following trade(s):
- On Friday, June 12th, Thomas Kosasa purchased 158,730 shares of OneMedNet stock. The stock was acquired at an average price of $0.63 per share, with a total value of $99,999.90.
- On Monday, May 18th, Thomas Kosasa purchased 268,817 shares of OneMedNet stock. The stock was acquired at an average price of $0.93 per share, with a total value of $249,999.81.
OneMedNet Price Performance
Shares of NASDAQ:ONMD opened at $0.62 on Friday. OneMedNet Corporation has a 1-year low of $0.44 and a 1-year high of $4.22. The stock has a market cap of $35.57 million, a P/E ratio of -12.49 and a beta of 1.14. The firm has a fifty day moving average price of $0.67 and a 200 day moving average price of $0.78.
OneMedNet (NASDAQ:ONMD - Get Free Report) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.04) EPS for the quarter. The business had revenue of $0.10 million for the quarter.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on ONMD shares. Wall Street Zen cut OneMedNet from a "hold" rating to a "sell" rating in a research report on Saturday, May 23rd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of OneMedNet in a research report on Monday, June 1st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, OneMedNet currently has an average rating of "Sell".
Check Out Our Latest Research Report on OneMedNet
Hedge Funds Weigh In On OneMedNet
Hedge funds and other institutional investors have recently bought and sold shares of the company. HRT Financial LP acquired a new position in OneMedNet in the 4th quarter valued at $32,000. Virtu Financial LLC purchased a new position in OneMedNet during the 4th quarter worth $48,000. Jane Street Group LLC acquired a new stake in shares of OneMedNet in the 4th quarter worth $119,000. State Street Corp lifted its stake in shares of OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company's stock worth $128,000 after acquiring an additional 34,200 shares during the period. Finally, Exencial Wealth Advisors LLC boosted its holdings in shares of OneMedNet by 1.3% in the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company's stock valued at $4,009,000 after acquiring an additional 45,401 shares in the last quarter. 0.95% of the stock is currently owned by hedge funds and other institutional investors.
About OneMedNet
(
Get Free Report)
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
